MASTER SERVICES AGREEMENT between Osiris Therapeutics, Inc. and Prolexys Pharmaceuticals, Inc.Master Services Agreement • September 14th, 2011 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Maryland
This Master Services Agreement (“Agreement”) is made on 31 August 2011 (the “Effective Date”) by and between Prolexys Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 410 Chipeta Way, Salt Lake City, UT 84108 (hereinafter “Prolexys”) and Osiris Therapeutics, Inc. a Maryland corporation, having its principal place of business 7015 Albert Einstein Drive, Columbia, MD 21046 (hereinafter “Osiris”). When signed and dated by both parties, this Agreement will set forth the terms and conditions under which Osiris agrees to provide certain Services to Prolexys as set forth herein.
